Disclaimer

Let's take a look at the attached clinical summary, which highlights the promise of Mesenchymal Stem Cells (MSCs) in treating Acute-on-Chronic Liver Failure (ACLF) . In this study, a total of 24 patients were treated with UC-MSC transfusions, and a significant increase in survival rates for ACLF patients was observed.

Liver cirrhosis treatment with autologous MSCs injection has shown promising results. 👍 This well-tolerated intervention has led to improvements in liver function, enabling patients to lead independent lives.  

In this article, the comparison between undifferentiated and differentiated autologous MSC transplantation in HCV-induced liver cirrhosis patients revealed no significant difference. However, compared to the control group, the improvements in clinical manifestations, attributed to the antifibrotic effects of MSCs was observed. 🔍

The article sharing here presents a compelling finding: liver cirrhosis, resulting from excessive alcohol consumption, may be treatable through the transplantation of autologous bone marrow MSCs. Each treatment session demonstrated a reduction in fibrosis without diminishing the treatment's efficacy.